Shanghai Menon Animal Nutrition Technology Co., Ltd.

SZSE:301156.SZ

17.65 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 99.853149.737132.487109.897.351129.78152.425131.19991.016166.719119.42491.052106.122156.28142.4113.995133.579141.94127.63775.49275.49280.63780.63759.33759.337
Cost of Revenue 71.736105.82593.56279.32270.04291.857103.70792.13865.74117.96882.77468.48775.019116.345-168.40378.50289.90188.143-92.63146.39846.39849.41949.41937.05837.058
Gross Profit 28.11743.91238.92530.47827.30937.92348.71939.06125.27648.75136.6522.56531.10339.936310.80335.49343.67953.798220.26829.09429.09431.21831.21822.27922.279
Gross Profit Ratio 0.2820.2930.2940.2780.2810.2920.320.2980.2780.2920.3070.2480.2930.2562.1830.3110.3270.3791.7260.3850.3850.3870.3870.3750.375
Reseach & Development Expenses 4.5476.3766.154.2344.1235.9047.4045.0123.6477.8226.6563.5493.3524.2866.4425.8025.785.645.644.1024.1024.534.533.0183.018
General & Administrative Expenses 7.553-17.09119.625-2.9736.6-14.1520.169-2.746.28512.13417.3010.3750.9597.9466.291-19.5276.0177.4877.4873.8923.8926.5776.5774.4294.429
Selling & Marketing Expenses 7.846-10.62620.0019.4047.9968.44211.32410.4937.35310.27510.2885.64.7388.54610.2398.898.1618.6688.6686.9586.95810.25210.2526.6226.622
SG&A 15.399-27.71739.6266.43214.021-5.70831.4937.75313.63824.69427.5885.9755.69615.76916.543-10.63714.17818.26918.26911.14111.14116.97116.97111.43311.433
Other Expenses -1.47945.471-20.191.47-0.341-0.1793.837-0.1490.00400.457-0.472-0.046-137.538-292.3071.8490.73-116.351-199.027000000
Operating Expenses 18.46724.1325.58621.62818.48526.04626.4625.1317.5231.94726.78312.80613.076-137.538-292.30718.45620.158-116.351-199.02714.55314.55320.46220.46214.41414.414
Operating Income 9.6519.78213.33910.4558.82314.52724.22117.16910.78914.02514.01310.23416.26718.74218.49618.85523.1125.58921.24114.32814.32810.17910.1797.967.96
Operating Income Ratio 0.0970.1320.1010.0950.0910.1120.1590.1310.1190.0840.1170.1120.1530.120.130.1650.1730.180.1660.190.190.1260.1260.1340.134
Total Other Income Expenses Net 0.146-0.163-0.0041.439-0.022-0.9313.142-0.6650.2933.8072.9630.004-0.046-0.853-0.139-1.5020.73-2.4621.8860.6380.6380.850.850.3180.318
Income Before Tax 9.79619.61813.33411.92511.44414.34828.05917.0210.79417.83213.99310.23816.22118.51718.35718.81323.8425.18321.07214.96614.96611.02911.0298.2778.277
Income Before Tax Ratio 0.0980.1310.1010.1090.1180.1110.1840.130.1190.1070.1170.1120.1530.1180.1290.1650.1780.1770.1650.1980.1980.1370.1370.1390.139
Income Tax Expense 0.9121.6471.7151.5181.3371.0793.3761.4661.2551.9321.1641.2371.462.1651.4832.0973.2243.3520.862.632.630.7910.7911.3321.332
Net Income 8.88317.97111.6210.4089.58413.26924.68315.5549.53915.912.839.00114.76116.35216.87416.71620.61621.83120.21112.33612.33610.23810.2386.9456.945
Net Income Ratio 0.0890.120.0880.0950.0980.1020.1620.1190.1050.0950.1070.0990.1390.1050.1180.1470.1540.1540.1580.1630.1630.1270.1270.1170.117
EPS 0.0630.1260.0810.0720.0860.120.220.0990.0850.110.110.080.180.110.120.110.250.190.190.110.110.0930.0930.0630.063
EPS Diluted 0.0630.1260.0810.0720.0860.120.220.0990.0850.110.110.080.180.110.120.110.250.190.190.110.110.0930.0930.0630.063
EBITDA 9.79819.62313.34211.86314.57819.15632.92421.78315.42116.51417.63413.06716.8520.87520.87622.1925.90623.37223.37216.01716.01711.85311.8539.6359.635
EBITDA Ratio 0.0980.1310.1010.1080.150.1480.2160.1660.1690.0990.1480.1440.1590.1340.1470.1950.1940.1650.1830.2120.2120.1470.1470.1620.162